1st Quarter - Report

STEPTOE LLP for NATIONAL ASSOCIATION OF CONVENIENCE STORES

Firm
Client
Income
$170,000
Expenses
—

What was lobbied

10 issue areas, each in the filer's own words, with who lobbied on it and where.

Gaming/Gambling/Casino GAM

Issues related to online gaming

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Telecommunications TEC

Issues related to data security

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Fuel/Gas/Oil FUE

Issues relating to price gouging

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Environment/Superfund ENV

Issues relating to interior appropriations legislation, climate change, renewable fuels. Issues of interest to motor fuels marketers including renewable fuels and underground storage tanks

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Energy/Nuclear ENG

Issues relating to motor fuels marketing

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Tobacco TOB

Issues relating to sales of tobacco products

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Food Industry (safety, labeling, etc.) FOO

Issues relating to the Combat Meth Act Food Safety Menu Labeling. Issues relating to the reauthorization of the supplemental nutrition assistance program

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Banking BAN

Issues related to banking and financial services reform legislation including: Credit Card Fair Fee Act, Credit Card Interchange Fees Act

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Roads/Highway ROD

Reauthorization of highway trust fund, including commercialization of interstate rest areas

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Taxation/Internal Revenue Code TAX

Issues relating to federal taxation of motor fuels and convenience store properties

LobbyistCovered position, as disclosed
LESLIE BELCHER —
R TIMOTHY COLUMBUS —
JESSICA FREND —
KATE LEANNE JENSEN —
ERIC MAY —
LISA MORTIER WALTZMAN —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.